Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain Cancers
Sarcoma Oncology Research Center, LLC
Sarcoma Oncology Research Center, LLC
Grupo Espanol de Investigacion en Sarcomas
Stanford University
National Cancer Institute (NCI)
Tempest Therapeutics
University Medicine Greifswald
Oncovir, Inc.